Completed PHASE3 INTERVENTIONAL NCT00266539

A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Scheduled Abdominal or Pelvic Surgery: The Fentanyl Transdermal System Versus the Morphine Intravenous Pump

Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by Fentanyl HCl Transdermal System Versus Morphine IV Pump for Pain Management After Non-emergent Abdominal or Pelvic Surgery

Sponsor: Alza Corporation, DE, USA

Conditions Pain, Postoperative

Interventions E-TRANS Fentanyl hydrochloride; Morphine

Updated 5 times since 2017 Last updated: May 18, 2011 Started: Apr 30, 2004 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Pain, Postoperative, this trial is completed. The trial is conducted by Alza Corporation, DE, USA and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alza Corporation, DE, USA
PriCara, Unit of Ortho-McNeil, Inc.

Data source: Alza Corporation, DE, USA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.